Target intelligence / Profile preview

Glycosaminoglycan Degradation Enzymes

Molecular classification
Enzyme, Hydrolase, Lyase
01

Overview

Glycosaminoglycan (GAG) degradation enzymes are a group of lysosomal hydrolases and lyases responsible for the stepwise breakdown of glycosaminoglycans—long, linear, negatively charged polysaccharides found in the extracellular matrix and on cell surfaces. GAGs include heparan sulfate, heparin, chondroitin sulfate, dermatan sulfate, keratan sulfate, and hyaluronan. These enzymes are essential for normal cellular turnover of GAGs and play critical roles in tissue remodeling, signaling regulation, and homeostasis. Degradation primarily occurs in lysosomes after endocytosis or phagocytosis of proteoglycans/GAGs. Inherited defects in these enzymes result in mucopolysaccharidoses—a group of lysosomal storage disorders characterized by accumulation of undegraded GAG fragments. Understanding these enzymes' activity is vital not only for basic biology but also for therapeutic strategies targeting lysosomal storage diseases or modulating tissue repair/regeneration through controlled ECM remodeling.

02

Mechanism of action

Hydrolytic or eliminative cleavage of glycosaminoglycans

03

Biological functions

Extracellular matrix remodelingRegulation of growth factor availabilityCell migrationWound healingGlycosaminoglycan catabolism
04

Disease associations

MucopolysaccharidosesLysosomal storage disordersCancerSkeletal abnormalitiesNeurodegeneration
05

Safety considerations

Off-target effects leading to excessive ECM breakdownPotential for immune reactions against engineered enzymesDifficulty in achieving tissue-specific targeting

Beyond the preview

Go deeper on Glycosaminoglycan Degradation Enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycosaminoglycan Degradation Enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call